Editorial: The Role of Microbiota in the Onset and Development of Intestine and Liver Diseases and Cancer: Molecular and Cell Mechanisms

Front Cell Dev Biol. 2022 Mar 9:10:852188. doi: 10.3389/fcell.2022.852188. eCollection 2022.

Fausto Andreola¹, Camilla Moliterni², Andrea Quagliariello³, Franco Scaldaferri^{4

5}, Marco Fidaleo^{2

6}

¹ Liver Failure Group, Institute for Liver and Digestive Health, Royal Free Hospital, University College London, London, United Kingdom.
² Department of Biology and Biotechnology Charles Darwin, University of Rome Sapienza, Rome, Italy.
³ Department of Comparative Biomedicine and Food Science, University of Padova, Padova, Italy.
⁴ Dipartimenti di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
⁵ CEMAD (Centro Malattie Apparato Digerente)-IBD UNIT-Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.
⁶ CNIS Research Center for Nanotechnology Applied to Engineering, Sapienza University of Rome, Rome, Italy.

No abstract available

Keywords: antibiotics; cirrhosis; diet; exercise; inflammatory bowel disease; liver cancer; microbiota; nonalcoholic fatty liver disease.

Publication types